Pharmacogenomics and chemical library screens reveal a novel SCFSKP2 inhibitor that overcomes Bortezomib resistance in multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacogenomics and chemical library screens reveal a novel SCFSKP2 inhibitor that overcomes Bortezomib resistance in multiple myeloma

Published:2016-09-28 Issue:3 Volume:31 Page:645-653
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Malek E,Abdel-Malek M A Y,Jagannathan S,Vad N,Karns R,Jegga A G,Broyl A,van Duin M,Sonneveld P,Cottini F,Anderson K C,Driscoll J J

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2016258.pdf

Reference49 articles.

1. Palumbo A, Anderson K . Multiple myeloma. N Engl J Med 2011; 364: 1046–1060.

2. Richardson PG, Mitsiades CS, Hideshima T, Anderson KC . Novel biological therapies for the treatment of multiple myeloma. Best Pract Res Clin Haematol 2005; 18: 619–634.

3. Richardson PG, Schlossman RL, Alsina M, Weber DM, Coutre SE, Gasparetto C et al. PANORAMA 2: panobinostat in combination with BTZ and dexamethasone in patients with relapsed and BTZ-refractory myeloma. Blood 2013; 122: 2331–2337.

4. Chauhan D, Tian Z, Nicholson B, Kumar KG, Zhou B, Carrasco R et al. A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes BTZ resistance. Cancer Cell 2012; 22: 345–358.

5. Maiso P, Huynh D, Moschetta M, Sacco A, Aljawai Y, Mishima Y et al. Metabolic signature identifies novel targets for drug resistance in multiple myeloma. Cancer Res 2015; 75: 2071–2082.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches;Molecular Cancer;2024-07-25

2. The ubiquitin-proteasome system in the regulation of tumor dormancy and recurrence;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07

3. The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer;Journal of Cancer Research and Clinical Oncology;2024-03-23

4. SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies;Frontiers in Oncology;2024-03-15

5. ATPase Copper Transporting Beta (ATP7B) Is a Novel Target for Improving the Therapeutic Efficacy of Docetaxel by Disulfiram/Copper in Human Prostate Cancer;Molecular Cancer Therapeutics;2024-02-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3